In addition, the first-line medications for patients with osteoporosis consist of bisphosphonates (BPs), selective estrogen receptor modulators, parathyroid hormone analogs, and therapeutic doses of calcium and vitamin D, which improve bone quality by inhibiting bone resorption, promoting bone formation, and supplementing bone nutrition (30). This evidence concerns the gene ESR1 and osteoporosis.